As proposals to ban surprise medical bills move through Congress and state legislatures with rare bipartisan support, physician groups have emerged as the loudest opponents

Quick Read

The $6 Million Drug Claim

August 26, 2019

New treatments for rare diseases are changing the lives of patients, but the price can reach millions of dollars for a single person

Quick Read

Forced off their parents’ insurance and faced with high insulin prices, young adults dangerously ration, stockpile, and turn to the black market for the medication they need to stay alive

Quick Read

Shortages of “supportive care” drugs, for chemotherapy-induced nausea or to protect the kidneys, can delay cancer treatments, said Yoram Unguru, a pediatric oncologist & bioethicist at Sinai and the Johns Hopkins Berman Institute of Bioethics. When he gets the hospital’s list of shortages, “I scream, I shout, I shake my head”

Quick Read

This Pharma Exec Is Accused Of Fixing Prices On 107 Drugs

Quick Read

More than 40 states say the biggest drug makers engaged in “industry-wide conspiracy” to fix prices of generic drugs

Quick Read

In Indiana, a local hospital system, Parkview Health, charged private insurance companies about quadruple what the federal Medicare program paid for the same care, according to a study of hospital prices in 25 states released on Thursday by the nonprofit RAND Corp

Quick Read

Novartis AG is expected to begin selling Zolgensma, a possible cure for spinal muscular atrophy, after the FDA approves it this month. Novartis executives say Zolgensma’s ability to curb SMA—a muscle-wasting disease that often kills babies before age 2—explains the eye-popping price

Quick Read